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Abstract
Optimally designing radiotherapy and radiosurgery treatments to increase
the likelihood of a successful recovery from cancer is an important application
of operations research. Researchers have been hindered by the lack of academic
software that supports head-to-head comparisons of different techniques, and
this article addresses the inherent difficulties of designing and implementing
an academic treatment planning system. In particular, this article details the
algorithms and the software design of Radiotherapy optimAl Design (RAD).
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1 Introduction
With the USA spending about 18% of its gross national product on health care,
the need to efficiently manage and deliver health services has never been greater.
In fact, some prominent researchers have claimed that if we are not judicious with
our resources, then our health care system will burden society with undue costs
and vast disparities in availability [10, 24]. Developing mathematical models that
allow us to study and optimize medical treatments is crucial to the overall goal of
efficiently managing the health care industry. Indeed, we have already witnessed
medical advances by optimizing existing medical procedures, leading to better patient
care, increased probability of success, and better time management.
Much of the previous work focuses on using operations research to improve ad-
ministrative decisions, but several medical procedures are now being considered. The
breadth and importance of these is staggering, and the academic community is poised
to not only aid managerial decisions but also improve medical procedures. One of the
most prominent examples of the latter is the use of optimization to design radiother-
apy treatments, which is the focus of this article.
Cancer remedies largely fall into three categories: pharmaceutical - such as chemother-
apy, surgical - whose intent is to physically remove cancerous tissues, and radiobio-
logical - which uses radiation to destroy cancerous growths. Radiotherapy is based on
the fact that cancerous cells are altered by radiation in a way that prevents them from
replicating with damaged DNA. When a cell is irradiated with a beam of radiation, a
secondary reaction forms a free radical that damages cellular material. If the damage
is not too severe, a healthy cell can likely overcome the damage and replicate nor-
mally, but if the cell is cancerous, it is unlikely that it will be able to regenerate. The
differing abilities of cancerous and non-cancerous cells to repair themselves is called a
therapeutic advantage, and the goal of radiotherapy is to deliver enough radiation so
that cancerous cells expire but not so much as to permanently damage nearby tissues.
Radiotherapy treatments are delivered by focusing high energy beams of ionizing
radiation on a patient. The goal of the design process is to select the pathways
along which the radiation will pass through the anatomy and to decide the amount of
dose that will be delivered along each pathway, called a fluence value. Bahr [6] first
suggested that we optimize treatments in 1968, and since then medical physicists
have developed a plethora of models to investigate the design process. Currently,
commercially available planning systems optimize only the fluence value and do not
additionally optimize the pathways. All of these commercially available systems rely
on some form of optimization algorithm and these algorithms can range from gradient
descent to simulated annealing. To date, the optimization approaches implemented
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clinically, typically by medical physicists working in the field of radiation oncology,
have been reasonably effective but have failed to exploit the significant advances of
robust operations research theory. As operations researchers have become aware of
such problems, increasingly sophisticated optimization expertise has been brought to
bear on the problem, leading to a growing potential for more elegant solutions.
The knowledge barrier between medical physicists, who understand the challenges
and nuances of treatment design, and operations researchers, who know little about
the clinical environment, is problematic. Clinical capabilities vary significantly, mak-
ing what is optimal dependent on a specific clinic (treatments also depend on an
individual patient). So, the separation of knowledge stems not only from the fact
that the operations researchers generally know little about medical physics, but also
from the fact that they typically know even less about the capabilities of a specific
clinic. This lack of understanding is being overcome by several collaborations between
the two communities, allowing academic advances to translate into improved patient
care.
One of the most significant research hindrances is the lack of head-to-head compar-
isons, with the vast majority of numerical calculations being undertaken by individual
research groups on patients from their associated clinic. This work describes the aca-
demic treatment system Radiotherapy optimAl Design (RAD), which is designed to
use
• standard optimization software to model and solve problems,
• a database to store cases in a well defined manner, and
• a web based interface for visualization.
The use of standard modeling software makes it simple to alter and/or implement
new models, a fact that supports head-to-head comparisons of the various models
suggested in the literature. Storing problems in a database is an initial step toward
creating a test bank that can be used by researchers to make head-to-head compar-
isons, and the web interface facilitates use. These features agree with standard OR
practice in which algorithms and models are compared on the same problems and on
the same machine.
The corresponding author once believed that a rudimentary version of RAD was
possible within a year’s effort. This was an extremely naive thought. RAD’s imple-
mentation began 1999, with the initial code being written in Matlab. The current ver-
sion is written in C++ and PHP and links to AMPL, CPLEX and a MySQL database.
At every turn there were numerical difficulties, software engineering obstacles, and
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verification problems with the radiation transport model. The current version re-
quired the concentrated effort of eight mathematics/computer science students, three
Ph.Ds in mathematics/computer science, and one Ph.D in Medical Physics spread
over 3 years. The details of our efforts are contained herein.
1.1 The Nature of Radiotherapy
Radiotherapy is delivered by immobilizing a patient on a horizontal table, around
which a linear accelerator or gantry, capable of producing a beam of radiation, rotates.
The table may be moved vertically and horizontally, allowing the central point of
gantry rotation, called the isocenter, to be placed anywhere in the anatomy, and may
be rotated in a horizontal plane. The gantry is capable of rotating 360 degrees around
the patient, although some positions are not allowed due to collision potential, see
Figure 1.
Treatment design is typically approached in 3 phases,
1) Beam Selection Select the pathways through which the radiation will pass through
the anatomy.
2) Fluence Optimization Decide how much radiation (fluence) to deliver along
each of the selected beams to best treat the patient.
3) Delivery Optimization Decide how to deliver the treatment computed in the
first two phases as efficiently as possible.
The first two phases of treatment design are repeated in the clinic as follows. A de-
signer uses sophisticated image software to visually select beams (also called pathways
or angles) that appear promising. The fluence to deliver along these beams is decided
by an optimization routine, and the resulting treatment is judged. If the treatment
is unacceptable, the collection of beams is updated and new fluences are calculated.
This trial-and-error approach can take as much as several hours per patient. Once an
acceptable treatment is created, an automated routine decides how to sequence the
delivery efficiently. There is an inherit disagreement between the objectives of fluence
and delivery optimization since a fluence objective improves as beams are added but
a delivery objective degrades. Extending the delivery time is problematic since this
increases the probability of patient movement and the likelihood of an inaccurate
delivery.
The initial interest in optimizing radiotherapy treatments was focused on fluence
optimization, and numerous models and solution procedures have been proposed,
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Figure 1: A standard treatment de-
livery system.
Figure 2: A multileaf collimator.
see [7, 17, 18, 25, 26] for reviews. The variety is wide and includes linear, quadratic,
mixed integer linear, mixed integer quadratic, and (non) convex global problems.
Clinically relevant fluence problems are large enough to make combining the first
two phases, which is trivial to express mathematically, difficult to solve, and much
of the current research is directed at numerical procedures to support a combined
model. One of RAD’s strengths is that it is designed so that different models and
solution procedures can easily be compared on the same cases, allowing head-to-head
comparisons that were previously unavailable.
There are many treatment paradigms, with one of the most common being Inten-
sity Modulated Radiotherapy (IMRT). This treatment modality is defined by the use
of a multileaf collimator housed in the head of the gantry. The leaves of the collima-
tor shape the beam, see Figure 2, and by adjusting the beam’s shape continuously
during treatment, we can modulate the delivered dose. The idea is to adjust the
leaves so that different parts of the anatomy receive variable amounts of radiation.
By combining several beams from multiple orientations, we hope to deliver a uniform
tumoricidal dose while sparing the surrounding healthy organs and tissues.
While the treatment advantages of a collimator are apparent, the collimator sig-
nificantly adds to the complexity of treatment design since it provides the ability
to control of small subdivisions of the beam. This is accomplished by dividing the
open-field into sub-beams, whose size is determined by the collimator. For example,
the collimator in Figure 2 has 32 opposing leaves that vertically divide the open-field.
Although the leaves move continuously, we horizontally divide the open-field to ap-
proximate the continuous motion and design a treatment that has a unique value for
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each rectangular sub-beam. The exposure pattern formed by the sub-beams is called
the fluence pattern, and an active area of research is to decide how to best adjust the
collimator to achieve the fluence pattern as efficiently as possible [1, 4, 9].
A radiotherapy treatment is designed once at the beginning of treatment, but
the total dose is delivered in multiple daily treatments called fractions. Fractioniza-
tion allows normal cells the time to repair themselves while accumulating damage to
tumorous tissues. The prescribed dose is typically delivered in 20 to 30 uniform treat-
ments. Patient re-alignment is crucial, and in fact, the beam of radiation can often
be focused with greater precision than a patient can consistently be re-aligned. Ra-
diosurgery treatments differ from radiotherapy treatments in that the total intended
dose is delivered all at once in one large fraction. The intent of a radiosurgery is to
destroy, or ablate, tissue. Patient alignment is even more important for radiosurgeries
because the large amount of radiation being delivered makes it imperative that the
treatment be delivered as planned.
2 Calculating Delivered Dose
The radiation transport model that calculates how radiation energy per unit mass
is deposited into the anatomy, which is called dose, is crucial to our ability to esti-
mate the anatomical effect of external beam radiation. Obviously, if the model that
describes the deposition of dose into the patient does not accurately represent the de-
livered (or anatomical) dose, then an optimization model that aids the design process
is not meaningful.
Numerous radiation transport models have been suggested, with the “gold stan-
dard” being a stochastic model that depends on a Monte Carlo simulation. This tech-
nique estimates the random interactions between the patient’s cells and the beam’s
photons, and although they are highly accurate, such models generally require pro-
hibitive amounts of computational time (although this is becoming less of a concern).
We instead adapt the deterministic model from [23] that approximates each sub-
beam’s dose contribution. The primary dose relies on the beam’s energy and on the
ratio between the radius of the sub-beam and the open-field. The way a sub-beam
scatters as it travels through the anatomy depends on the radius of the sub-beam.
Small radius beams have a large surface area compared to their volume, and hence,
they lose a greater percentage of their photons than do larger radius sub-beams.
When many contiguous sub-beams are used in conjunction, much of this scatter is
gained by surrounding sub-beams, called scatter dose buildup.
The radiation transport model estimates the rate at which radiation is deposited,
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and we let D(p,a,i) be the rate at which dose point p gains radiation from sub-beam
i in angle a. A few comments on the term ‘dose point’ are warranted. Much of the
literature divides the anatomy into 3D rectangles called voxels and then considers the
amount of radiation delivered to an entire voxel. This approach is well suited to other
radiobiological models, but the one that we use is based on geometric distances. To
calculate these distances, we represent each voxel by its center and call this a dose
point. The units of D(p,a,i) are Grays per fluence, where one Gray is equal to 1 joule
per kilogram. The triple (p, a, i) defines the depth d of dose point p along sub-beam
(a, i), see Figure 3. Beams attenuate as they pass through the anatomy, meaning
that lose energy as they pass through tissue. The maximum accumulation is not at
the anatomy’s surface but rather at a depth of M due to the previously mentioned
dose buildup, after which the attenuation is modeled as exponential decay, e−µ(d−M),
where µ is an energy parameter. For a 6MV beam, the maximum dose rate is typically
observed to occur at a depth of 1.5 cm. The dose rate at the surface is approximately
60% of the maximum rate at depthM , and we linearly interpolate between this value
at depth 0 and the maximum rate at depth M . While this interpolation is not exact,
it is reasonable and the majority of critical structures are at depths greater than M .
The dose model we use is
D(p,a,i) =


(
P0 e
−µ(d−M)(1− e−γr) + rdαd
r+M
)
× ISF × O, d ≥M
(
0.4d
M
+ 0.6
)
×
(
P0 (1− e
−γr) + rMαM
r+M
)
× ISF ×O, 0 ≤ d < M.
The primary dose contribution for depths at least M is P0 e
−µ(d−M), where P0 is a
machine-dependent constant. The factor (1− e−γr) represents the percentage of the
open-field radiation present in a sub-beam, where γ is experimentally defined and r
is the radius of the sub-beam. Notice that as r decreases the sub-beam’s intensity
falls exponentially, so extremely small sub-beams are not expected to effectively treat
deep tissue malignancies. The term (rdαd)/(r+M) models the scatter contributions
from the surrounding sub-beams, where
αd = −0.0306 ln(d) + 0.1299.
Again, the contribution from scatter decreases with r (although linearly instead of
exponentially).
The final two factors are the inverse square factor, ISF , and the off-axis factor,
O. The inverse square factor is the square of the ratio of the distance from the
gantry to the isocenter and the distance from the gantry to the dose point. Allowing
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Figure 3: The geometry of a radio-
biological model.
Figure 4: The dose contour of a sin-
gle sub-beam.
l(s, isocenter) and l(s, p) to be the distances from the source s to the isocenter and
from s to the dose point p, we have
ISF =
(
l(s, isocenter)
l(s, p)
)2
.
The off-axis factor adjusts the dose contribution so that dose points near a sub-beam
accumulate radiation faster than those that are farther away. This factor depends
on the off axis distance o in Figure 3 and is machine and beam energy dependent,
making it necessary to use a table tailored to a specific machine. Linear interpolation
is performed to determine off axis contributions for distances not listed in the table.
For distances greater than M , Nizin [23] reports that the maximum error is 5%
for clinically relevant beams when compared to Monte-Carlo models. For extremely
narrow beams, which are not clinically relevant, there is a maximum error of 8%. For
our purposes, this level of accuracy is sufficient.
The dose rates discussed in the previous section are arranged to form a dose
matrix, denoted by A, whose rows are indexed by p and whose columns are index by
(a, i). Allowing x(a,i) to be the fluence of sub-beam i in angle a, the cumulative dose
at point p is ∑
(a,i)
D(p,a,i)x(a,i) = (Ax)p,
where the indices of the vector x correspond to the columns of A. So, the linear map
x 7→ Ax transforms a fluence pattern into anatomical dose (Gy).
Although Figure 3 depicts angle a being divided into ‘flat’ sub-beams, the colli-
mator segments a beam into a 2D grid. The column widths of the grid are decided by
8
the width of the leaves, and the row widths depend on the type of collimator. Some
collimators are binary, and each leaf is either open or closed. Other collimators allow
each leaf to move continuously across the column, and in this situation the rows of the
grid are used to discretize this continuous motion. The subscript i indexes through
this grid at each angle, and hence, i is actually a 2D index. Similarly, the index for
angles need not be restricted to a single great circle around the patient, and the index
a represents an angle on a sphere around the patient.
3 Coordinate Systems
A complete foray into the authors’ tribulations with the different coordinate systems
is beyond the scope of this article, but a few notes are important. There are three
coordinate systems that need to be aligned, 1) the coordinates for the patient images,
2) the coordinates for the dose points, and 3) the location of the gantry. The patient
images are three dimensional of the form (µ, ν, ζ), where each ζ represents a typical
cross sectional image. The images are not necessarily evenly spaced, with images
often being closer through the target. The dose points are also three dimensional of
the form p = (u, v, z). As discussed below, placement of these points is restricted to
an underlying, evenly space grid, and hence, the z coordinate do not necessarily agree
with ζ . However, each dose point needs to be linked to a tissue that is defined by an
image, and we associate (u, v, z) with (u, v, ζz), where ζz is the closest ζ to z. The
gantry coordinates describe the machine and not the anatomy. To link the gantry’s
position and rotation to the patient, we need to know the location of the isocenter
within the patient and the couch angle. Gantry coordinates are calculated in polar
form and translated to rectangular coordinates that are synced with the anatomy’s
position on the couch.
Our solution to aligning the coordinate systems is to build a three dimensional
rectangle whose coordinates are fixed and whose center is always the location of the
isocenter. We load the patient images into the rectangle so that they position the
isocenter accordingly, and then build a three dimensional grid in the rectangle that
defines where dose points are allowed to be placed. The couch angle defines a great
circle around the fixed rectangle that allows us to position and rotate the gantry,
which in turn allows us to track the sub-beams as they gantry moves.
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4 Optimization Models
The linear operator x 7→ Ax facilitates an optimization model. For convenience, we
sub-divide the rows of A into those that correspond to the target, critical structures,
and normal tissue, and we let AT , AC , and AN be the corresponding sub-matrices
so that ATx, ACx and ANx are the anatomical doses for the target, the critical
structures, and the normal tissue. Physicians form a prescription by placing bounds
and goals on the anatomical dose. The precise definition of a prescription depends on
the definition of an optimal treatment. For example, a simple least squares model is
min{ω1‖ATx− TG‖2 + ω2‖ACx‖2 + ω3‖ANx‖2 : x ≥ 0}. (1)
The prescription for this model is the vector of goal doses for the targeted region,
TG, which is commonly a scalar multiple of the vector of ones. The ω scalars weight
the terms of the objective to express clinical preference. A linear model with a more
complicated prescription is
min{ω1 · α+ ω2 · β + ω3 · γ : TLB − αe ≤ ATx ≤ TUB, ACx ≤ CUB + βe,
ANx ≤ NUB + γe, 0 ≤ ATx ≤ TLB, β ≥ −‖ − CUB‖∞, γ ≥ 0}, (2)
where e is the vector of ones (length is decided by the context of its use). The
prescription for this model is TLB - vector of lower bounds for the target, TUB -
vector of upper bounds for the target, CUB - vector of upper bounds for the critical
structures, NUB - vector of upper bounds for the normal tissues, and the weighting
values ωi, i = 1, 2, 3. Both (1) and (2) are fluence problems since they define an
optimal treatment for a known set of angles, sub-beams and dose points. In general,
a prescription is the information provided by a physician that is used to define an
instance of a fluence problem. Table 1 shows the prescription information gathered by
RAD. The ABSMIN and ABSMAX information is used in some models to define
‘hard’ constraints instead of the goals suggested by other bounds. For example,
the model below differentiates between the goal lower bound TLB and the target’s
absolute minimum bound ABSMINT .
min{‖z‖2 : ABSMINT ≤ ATx ≤ TUB+z, ACx ≤ CUB+z, ANx ≤ NUB+z, x ≥ 0}.
The hard constraint ABSMINT ≤ ATx guarantees the target will receive at least
the values in ABSMINT , whereas TUB, CUB and NUB are goals parametrized by
z.
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Notation Description
Goals TG A goal dose for a target.
TLB A goal lower bound for a target.
TUB A goal upper bound for a target.
CUB A goal upper bound for a critical structure.
NUB A goal upper bound for the normal tissues.
Dose Bounds ABSMAX An absolute maximum dose allowed on any structure.
ABSMIN An absolute minimum dose allowed on the target.
Error Bounds PERABV Percent of volume allowed to violate an upper bound.
PERBLW Percent of volume allowed to violate a lower bound.
Table 1: Prescription information gathered by RAD. Each of these vectors is indexed
to accommodate the required number of structures.
Error bound parameters are commonly used in what are called dose volume con-
straints, which limit the volume of tissue allowed to violate a goal. For example, a
mixed integer extension of (1) that limits the amount of under irradiated target is
min{ω1‖ATx− TG‖2 + ω2‖ACx‖2 + ω3‖ANx‖2 :
(1− yp)
∑
(a,i) A(p,a,i)x(a,i) ≤ TLB,
∑
p∈T yp ≤ PERBLW · |T |, y ∈ {0, 1}
|T |, x ≥ 0}.
These are notoriously difficult problems with a substantial literature, see [13, 19] as
examples.
Once an optimization model is decided, an optimal treatment can be calculated
using a host of different solvers. If the model is linear, solver options include the
primal simplex method, the dual simplex method, Lemke’s algorithm, and several
interior point methods. Unless the optimization problem has a unique solution, it is
likely that different solution algorithms will terminate with different fluence patterns
(although the objective values will be the same). This phenomena has been observed
in [14], where CPLEX’s dual simplex was shown to routinely design treatments with
a few angles having unusually high fluences. If the model is nonlinear but smooth,
typical options are gradient descent, Newton’s method, and variants of quasi-Newton’s
methods.
In the spirit of RAD’s academic intent, one of our goals is to allow easy and seam-
less flexibility in how optimal treatments are defined and calculated. This is possible
by using pre-established software that is designed to model and solve an optimization
problem. In particular, we separate data acquisition, modeling, and solving. This
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differs from the philosophy behind most of the in-house systems developed by indi-
vidual clinics, where modeling and solving are intertwined in a single computational
effort. The mingling of the two complicates the creative process because changing
either the model or the solution procedure often requires large portions of code to be
rewritten, thus hindering exploration. We instead use standard software to model and
solve a problem. For instance, RAD uses AMPL to model problems, which makes
adjusting existing models and entering new ones simple. AMPL links to a suite of
35 solvers such as (integer) linear and (integer) quadratic models (as well as many
others). RAD currently has access to CPLEX, MINOS and PCx. This approach
takes advantage of the numerous research careers that have gone into developing
state-of-the-art software to model and solve optimization problems, and hence brings
a substantial amount of the field of Operations Research to the design of radiotherapy
treatments.
There are limitations to this design approach, especially with global (non-convex)
problems that are often successfully solved with simulated annealing or other heuris-
tics. The lack of access to quality heuristics for global optimization problems is
a detriment because one of the industry’s primary solution methods is simulated
annealing. Simulated annealing has the favorable quality that it can successfully
accommodate any model, but the unfavorable quality that there is no guarantee of
optimality. However, the medical physics community has learned to trust this tech-
nique because it has consistently provided quality treatments. Moreover, some of
the suggested optimization models are non-convex global models. A future goal is to
link RAD to global solvers like LGO, simulated annealing, and genetic algorithms.
Once this is complete, a large scale study of which model and solution methodology
provides the best clinical benefit is possible. Wide scale testing of different models
and solution procedures has not been undertaken, but RAD has the potential to
support this work. Such work is important because clinical desires vary from clinic
to clinic and from physician to physician. This leads to the situation where the sense
of optimality —i.e. the optimization model, can be different from one physician to
another for the same patient. It is possible, however, that the basic treatment goals
pertinent to all clinics and physicians are best addressed by a single model and solver
combination. If this is true, then such a model and solver combination would pro-
vide a consensus on what an optimal treatment is for a specific type of cancer and a
subsequent standard of care for clinics with similar technology.
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5 Problem Management
The size of a typical design problem is substantial, making them difficult to solve.
Indeed, the results in [12] show that storing the dose matrix can require over 600
Gigabytes of memory. For this reason, it is necessary to use reduction schemes to
control the size of a problem, and this section discusses the methods introduced in
RAD, several of which are designed to assist the combination of beam selection and
fluence optimization.
The current practice of asking the treatment planner to select beams has the
favorable quality that the underlying fluence problem only considers the selected
beams, which reduces the number of columns in the dose matrix A. RAD is capable
of addressing a fluence problem with a large number of candidate beams by judiciously
selecting sub-beams and dose points. The first reduction is to simply remove the sub-
beams that do not strike the target. One naive way to remove these sub-beams is to
calculate an entire dose matrix and then remove the columns whose aggregate rate
to the target is below a specified threshold. RAD’s approach is different, and before
calculating the rates associate with a sub-beam, we search for the minimum off-axis
factor over the dose points on the surface of the target. If the minimum value is too
great, we classify the sub-beam as non-target-striking and are spared the calculation
of this column. This technique requires two calculations that are not needed by the
naive approach, that of locating the target’s surface and evaluating the minimum
off-axis factor. Both of these calculations only consider the target, whereas the naive
approach calculates rate information for each point in the anatomy. Our numerical
comparisons, even for large targets, show that RAD’s approach is significantly faster.
A novel reduction introduced inRAD is to accurately define the anatomical region
that will receive significant dose. For example, consider a lesion in the upper part
of the cranium. The volume defined by the entire set of patient images is called the
patient volume, and for this example it would likely encompass the head and neck.
However, it is unlikely that we will need to calculate dose in the neck region. We
have developed a technique that defines a (typically much) smaller volume within the
patient where meaningful dose is likely to accumulate.
Assume that a designer considers a unique great circle around the patient by
selecting a single isocenter and couch angle, represented by the pair (c, j). Further
assume that beams will be selected from the collection of beams placed every 5o on
this great circle. Using only the sub-beams that strike the target, we trace them
through the anatomy to define a swath. A mathematical description highlights the
ease with which this region can be calculated. Let B0 be the plane defined by the
gantry as it rotates around the isocenter with a fixed couch angle. B0 is defined by
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the unit normal vector N and the isocenter c0: B0 = {c0 + Nν : Nν = 0}. Two
additional planes B1 and B2 are defined using the same normal vector N , so that
they are parallel to B0, but with the respectively different points,
c1 = (max {dist(E(i), B0) : i ∈ S}+ r)N
c2 = (min {dist(E(i), B0) : i ∈ S} − r)N.
In this calculation, S is the set of all sub-beams that are target striking and E is the
map from S into R3 so that E(i) is the point where sub-beam i exits the anatomy.
The distance between this point and the B0 plane is
dist(E(i), B0) =
NTE(i)−NT c0
‖N‖
.
Note that this is the signed minimum distance between a point and a plane. Points
in the direction of N have a positive distance, and points in the direction of −N have
a negative distance. Allowing D to be the collection of all possible dose points in the
patient volume defined by the entire set of images, we define the swath for isocenter
c and couch angle j to be
W(c,j) = {d ∈ D : dist(d,B1) ≤ 0} ∩ {d ∈ D : dist(d,B2) ≥ 0}.
This development shows that constructing the swath is computationally simple be-
cause we only need to iterate over the elements of S, which are already defined by
the first reduction, calculate dist(E(i), B0), and keep the maximum and minimum
elements. We additionally add any delineated critical structures that lay outside this
region. The combined region is called the treatment volume for (c, j). If there are
further isocenters and couch angles, the entire treatment volume is the union over all
(c, j). Dose points are only placed within this volume for planning purposes, reducing
the number of rows of the dose matrix.
The arrangement of dose points over the treatment volume is critical for two
reasons: 1) the discrete representation of the anatomical dose needs to accurately
estimate the true continuous anatomical dose, and 2) the size of the problem grows as
dose points are added. Clinical relevance is achieved once the dose points are within
2mm of each other. Some technologies are capable of taking advantage of 0.1mm
differences, and hence, require much finer grids. Our experiments show that using
the treatment volume instead of the patient volume reduces the storage requirement
to 10s of Gigabytes instead of 100s of Gigabytes with a grid size of 2 mm, assuming
a single isocenter and couch angle. Although this is a significant reduction, solving a
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linear or quadratic problem with a dose matrix in the 10 Gigabyte range is impossible
with CPLEX on a 32 bit PC, there are simply not enough memory addresses.
Our final reduction is a technique that iteratively builds a dose matrix for the
treatment volume. The idea is to eliminate the numerous dose points in the normal
tissue that are largely needed to protect against a hot spot, which is clinically defined
as a cubic centimeter of tissue receiving an unusually high dose, say 110% of the
average target dose. While hot spots are not desired in any part of the anatomy,
including the target, the general consensus is that hot spots should never be located
outside the target. Our final reduction scheme attempts to ensure that we place
normal tissue dose points so that we can monitor areas likely to have hot spots while
eliminating the dose points in the normal tissue that do not influence the problem.
RAD uses the following iterative procedure:
1. On the first solve we only include normal tissue dose points that are adjacent
to the target, forming a collar around the target. This concept was used in the
earliest work in the field [5].
2. We segment the patient volume into 1cm3 sectors.
3. We trace the sub-beams that have sufficiently high fluence values, and each
sector is scored by counting the number of high fluence sub-beams that pass
through it.
4. Normal tissue dose points are placed within the treatment volume for the sectors
that have high scores.
5. The process repeats with the added dose points until every sector receives a
sufficiently small score.
This iterative procedure solves several small problems instead of one large one. On
clinical examples, the initial dose matrices are normally under 1 Gigabyte, a size
that is appropriate for the other software packages. We point out that RAD does
not calculate the anatomical dose to each sector but rather only counts where high
exposure sub-beams intersect. Just because a few high exposure sub-beams pass
through a sector does not mean that this sector is a hot spot, but it does mean that
it is possible. Sectors with low counts can not be hot spots because it is impossible
to accumulate enough dose without several high exposure sub-beams. We find that
1 to 5 iterations completely removes hot spots outside the target. At the end of
the process, the dose matrix has typically grown negligibly and remains around 1
Gigabyte in size.
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The iterative procedure above reduces the number of rows of the dose matrix so
dramatically and successfully that we can increase the number of beams. Although
a clinic will only use a fraction of the added beams, solving for optimal fluences
with many beams provides information about which beams should and should not
be selected. A complete development of beam selection is not within the scope of
this work, and we direct readers to [14] for a complete development. Beam selectors
are classified as uninformed, weakly informed or informed. An uninformed selector
is one that only uses geometry, and the current clinical paradigm of selecting beams
by what looks geometrically correct is an example. A weakly informed selector is
guided by the dose matrix and the prescription, and an informed selector further
takes advantage of an optimal fluence pattern calculated with a large set of possible
beams. The premise behind an informed selector is that it begins with a large set
of possible beams that are allowed to ‘compete’ for fluence through an optimization
process. The expectation is that a beam with a high fluence is more important than
a beam with a low fluence. The numerical results in [14] demonstrate that informed
selectors usually select quality beams in a timely fashion.
RAD is designed to study beam selection and fluence optimization and is well
positioned to address the current research pursuit of simultaneously optimizing both
fluence and beams [2, 3, 20]. Rather than asking a user to identify beams, users are
instead asked to select collections of couch angles and isocenters, which is clinically
easier. RAD then places angles on each of the great circles, calculates the treatment
volume, and uses the iterative procedure above to control hot spots. Beams are
typically spaced at 5o increments on each of the great circles. The resulting optimal
treatment is not clinically viable but is available for an informed beam selector. Of
course, uninformed and weakly informed beam selectors are possible as well, but
RAD provides the additional option of using an informed selector. Once beams are
selected, RAD places dose points on a fine mesh (spacing no greater than 2 mm)
throughout the treatment volume. Since the number of beams is small, this leads
to a dose matrix that remains appropriate with our other software packages. A final
optimal treatment is calculated with this matrix. Table 2 contains the expected size
reductions for a 20cm3 region.
We conclude this section with a brief discussion about sparse matrix formats
and other reductions that did not work. A straight forward approach of reducing
the storage requirements of the dose matrix is to store only those values above a
predefined threshold. This method requires the calculation of every possible rate
coefficient over the patient volume. Our approach of defining the treatment volume
preempts the majority of these calculations and is faster. That said, about 90% of
the rate coefficients over the treatment volume are insignificant since each sub-beam
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Size Number of Rows Number of Columns Size of A
Patient Volume 106 1.3× 105 1.3× 1011
Sequential Solves 3.0× 104 8.4× 102 2.5× 107
Final Solve 3.8× 105 4.0× 10 1.5× 107
Table 2: Approximate dose matrix sizes for a 20cm3 region with 3 couch angles
around a single isocenter in the middle of the patient volume. A 2mm 3D grid
spacing is assumed. Each swath is 1cm in width (6 dose points wide), is parallel to
one of the axes, and passes through the center of the patient volume. The example
assumes that 10, 000 dose points in the treatment volume are not normal and that
20, 000 additional dose points outside the treatment volume are needed to describe
the critical structures. Each beam is assumed to have a 25 × 25 grid of sub-beams,
of which 4 are assumed to strike the target. The final treatment has 10 angles.
delivers the majority of its energy to a narrow path through the treatment volume.
So, a sparse matrix format over the treatment volume should further reduce our
storage requirements. However, our reduction schemes allow us to forgo a sparse
matrix format and store a dose matrix as a simple 2D array with double precision.
This simplicity has helped us debug and validate the code.
Before arriving at the reductions above, we attempted a different method of plac-
ing dose points. The idea was to use increasingly sparse grids for the target, critical
structures, and normal tissues. This is not a new idea, with different densities being
considered in [21, 22]. There are two problems with this approach. First, the voxels
of different grids have different volumes, and our code to handle the volumes at the
interface of different grids was inefficient. Second, the sparsity of the normal tissue
grid had to exceed 1 cm (often 2+ cm) to accommodate the use of many angles. This
is well beyond clinically acceptable values. Moreover, the sparsity did not prevent hot
spots from appearing in the normal tissue. We are aware that Nomos’s commercial
software uses an octree technique that allows varying densities, so it is possible to use
this idea successfully, although our attempt failed.
6 Solution Analysis
A treatment undergoes several evaluations once it is designed. In fact, the number of
ways a treatment is judged is at the heart of this research, for if the clinicians could tell
us exactly what they wanted to optimize, we could focus on optimizing that quantity.
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However, no evaluative tool comprehensively measures treatment quality, making the
problem inherently multiple objective [15, 16]. The issue is further complicated by
the fact that treatment desires are tailored to specific patients at a specific clinic.
That said, there are two general evaluative tools.
A Dose Volume Histogram (DVH) is a graph that for each structure plots dose
against percent volume, which allows a user to quickly evaluate how the entirety of
each structure fairs. A treatment and its corresponding DVH from the commercial
system Nomos are found in Figures 5 and 6. The upper most curve of the DVH
corresponds to the target, which is near the brain stem. This curve starts to decrease
at about 52 Gy, which indicates that 100% of the target receives at least this dose.
The next highest curve represents the spinal cord, a structure whose desired upper
bound is 45 Gy. This curve shows that about 18% of the spinal cord is to receive a
higher dose. The remaining curves correspond with the eye sockets and remaining
normal tissue.
Figure 5: The isodose contours for a
clinically designed treatment.
Figure 6: The DVH for the treatment
in Figure 5.
Notice that a DVH curve depends on the volumetric estimate of the corresponding
structure, an observation that leads to a subtle issue. Different clinics are likely to
create different volumes of the normal tissue by scanning different patient volumes.
This means the curve for normal tissue will vary, and in particular, the information
provided by this curve diminishes as more normal tissue is included. For example, if
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we are treating the lesion in Figure 5, we could artificially make it appear as though
less than 1% of the normal tissue receives a significant dose by including the tissue
in the patient’s feet. The authors of this paper are unaware of any standard, and
for consistency, all of RAD’s DVHs are based on the treatment volume, which is a
definable and reproducible quantity that removes the dependence on the clinically
defined patient volume.
A DVH visually displays the amount of a structure that violates the prescription
but does not capture the spacial position of the violation. If 10% of a structure’s
volume violates a bound but is distributed throughout the structure, then there is
likely no radiobiological concern. However, if the volume is localized, then it might be
a hot spot and the treatment is questionable. To gain spatial awareness of where dose
is and is not accumulated, each of the patient images is contoured with a sequence
of isodose curves. Examples are found in Figure 5. Each of these curves contains
the region receiving dose above a specified percentage of the target dose. So, a 90%
isodose curve contains the tissue that receives at least 0.9 × TG. Isodose curves
clearly indicate the spatial location of high dose regions, but they require the user
to investigate each image and form a mental picture of the 3D dose. Since there are
often hundreds of scans, this is a tedious process.
Rendering isodose curves proved more complicated than we had first assumed,
and RAD incorporates a new approach. We build a cubic approximation of the
continuous dose with a B-spline. Let δ(k,t), δ(k+1,t), δ(k,t+1) and δ(k+1,t+1) be the dose
at four neighboring dose points on one of the patient images (recall that dose on a
image is associated with the dose at the closest dose point - since we are dealing
with a single image, we remove the ζ coordinate). The cubic approximation over this
region is
S(k,t)(µ, ν) = (1/36)UMQ(k,t)M
TV T , 0 ≤ µ, ν,≤ 1,
where U = [µ3, µ2, µ, 1], V = [ν3, ν2, ν, 1],
M =


−1 3 −3 1
3 6 3 0
−3 0 3 0
1 4 1 0

 and Q(k,t) =


δ(k−1,t−1) δ(k−1,t) δ(k−1,t+1) δ(k−1,t+2)
δ(k,t−1) δ(k,t) δ(k,t+1) δ(k,t+2)
δ(k+1,t−1) δ(k+1,t) δ(k+1,t+1) δ(k+1,t+2)
δ(k+2,t−1) δ(k+2,t) δ(k+2,t+1) δ(k+2,t+2)

 .
By design, these regional approximations combine to form a smooth approximation
over the entire patient image, which is
S(µ, ν) = S(⌊µ⌋,⌊ν⌋)(µ− ⌊µ⌋, ν − ⌊ν⌋),
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where (µ, ν) ∈ [1, m] × [1, n]. If the indexing exceeds the image, then exterior dose
values are interpreted as the dose of their nearest neighbor. For example, δ(0,0) =
δ(1,0) = δ(0,1) = δ(1,1), of which δ(1,1) is the only real dose value.
This is a traditional (uniform) B-spline, and nothing is new about continuously
approximating discrete information with this technique. However, the cubic estima-
tion allows us to draw an isodose curve by finding a level curve of S(µ, ν) –i.e. the
solutions to S(µ, ν) − αTG = 0, where 0 ≤ α ≤ 1. What is new is that we use
a shake-and-bake algorithm to identify the isodose curve [8]. The idea is to start
within the region of high-dose, randomly select a direction, and then find the high
dose boundary along the forward and backward rays. Formally, fix α between 0 and
1 so that we are looking for the α isocontour. Let (µ0, ν0) be a position on the patient
image such that the dose δ(µ0,ν0) is greater than αTG. Uniformly select ρ0 in [0, pi),
and along the line segment (µ0, ν0) + θ(cos(ρ), sin(ρ)), find the smallest positive θ
and largest negative θ such that either S((µ0, ν0) + θ(cos(ρ0), sin(ρ0)))−αTG = 0 or
θ is at a bound that prevents the coordinate from leaving the patient image. This
calculation renders a line segment defined by θmax0 and θ
min
0 , and the next iteration
begins with the midpoint of this segment,
(µ1, ν1) = (µ0, ν0) + (1/2)(θ
max
0 + θ
min
0 )(cos(ρ0), sin(ρ0)).
This technique has the favorable mathematical property that if the region within the
isocontour is convex, then the random sequence (µk, νk)+θ
max(or min)
k (cos(ρk), sin(ρk))
converges to the uniform distribution on the isocontour [8]. Moreover, it is suspected,
although not proved, that the uniformity is achieved for any connected region [11].
An example is shown in Figure 7.
We let (µ0, ν0) be the location of the dose point with the maximum dose. We
mention that this may or may not be the largest value of S(µ, ν), and another option
would be to solve ∇S(µ, ν) = 0 to find its maximum value. We use Newton’s Method,
with a full step, to solve S((µ0, ν0) + θ(cos(ρ0), sin(ρ0))) − αTG = 0, which has
favorable quadratic convergence and is simple to implement since the partials of
S(µ, ν) are
∂
∂µ
S(k,t)(u, v) = (1/36)UIˆMQ(k,t)M
TV T
and
∂
∂ν
S(k,t)(u, v) = (1/36)UMQ(k,t)M
T IˆTV T ,
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Figure 7: A 90% isocontour rendered with the shake-and-bake algorithm.
where
Iˆ =

 0 0 01 0 0
0 1 0

 .
Many alternative line searches are available, such as a binary search, and such tech-
niques may provide stability if the gradient of S is near zero. Lastly, we mention that
this method renders an unordered collection of points on the isocontour, and without
an order, it is not clear how to connect them. This is not a concern if enough points
are rendered, for after all, every displayed curve is a collection of pixels.
7 Software Design & Structure Identification
The previous sections’ discussions about the algorithms that support RAD do not
address the software engineering aspects, and the authors would be remiss if they
did not discuss how the different parts of RAD interlink. Some of the topics in this
section are general software issues and others are specific to the design of radiotherapy
treatments.
The basic idea behind our approach is to exploit a language’s strengths. As Table 2
indicates, the number of calculations needed to form a dose matrix is significant,
and this part of the project is written in C++. Dose matrices may be written to
disc for debugging purposes or they may be kept in memory and passed directly to
other applications. Reading and writing a 1 Gigabyte file from and to disc is time
consuming, and the latter approach saves time, especially when everything stays in
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MySQL, stores and retrieves
problem information
DoseCalc, written in C++,
and compiled as a php module
AMPL, commercial modeling
language
The php scripting language
Visualization, written in php
Solvers, such as CPLEX,
MINOS, etc....
Figure 8: The SWIG compiler links PHP to C++, which in turn allows us to pass
information between DoseCalc (the parallel implementation of our radio-biological
model) and other software.
RAM. We use the SWIG compiler to link our C++ code to the scripting language
PHP, which allows the dose matrix to be stored in a native PHP structure. Through
the use of a bi-directional pipe, we can pass the dose matrix to other applications
like AMPL and receive information when a problem is solved. Moreover, PHP gives
us control of the linux command line, naturally interfaces with MySQL, and easily
interfaces with the web to support the user interface. For these reasons, PHP became
the ‘glue’ that held the system together, and the power of this ability should not be
under estimated. Figure 8 depicts the general design.
Another ofRAD’s unique features is that it stores problems in a MySQL database.
Beyond being an information repository for RAD, its intent is to become a library of
problems for head-to-head comparisons. The medical literature on treatment design
is vast, but each paper highlights a technique on a few examples from a specific clinic,
examples that can not be used by others to compare results. This is strange from
a computational perspective, and RAD’s database will support the numerical work
necessary to fairly evaluate different algorithms and models.
A natural question about data storage is, What is a problem? In other words, what
data is needed to define a problem instance. We adhere to the following structure,
Problem = (Case, Prescription, Settings)
Solution = (Problem, Model, Solution Technique).
A Case is defined by the geometry of the patient. We parse RTOG files (a standard
protocol for radiotherapy treatments) to gain a description of the structures that were
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delineated on the patient images. Each structure is defined by a series of polygons on
individual patient images, with each polygon being defined by an ordered list of points.
We construct a continuous boundary for each structure by linearly joining consecutive
points on each image. We mention that other splining techniques were tested in an
attempt to make the structural boundaries smooth, but none were more accurate when
overlaid on the CT scan. Some structures, such as the kidney shown in Figures 9
and 10, may be described by several polygons on the same slice, creating geometries
that complicate the process of automatically defining the regions associated with each
tissue. The regions defined by these curves may or may not be contained within each
other. If the regions are disjoint, we assume they enclose the same tissue. However,
if one of the regions is within the other, such as in Figure 9, we assume the region
defined by the inner curve is not part of the defined tissue. To test whether or not
the regions are disjoint, we calculate a winding number. Let (µk, νk) and (µˆk, νˆk)
be two lists of points on the same image for the same structure. To see whether
or not the polygon defined by (µˆk, νˆk) is within the polygon defined by (µk, νk), we
select a single (µˆK , νˆK) and consider the vertical line through this point. For every
directed line segment from (µk, νk) to (µk+1, νk+1) that passes the vertical line above
(below) (µˆK , νˆK) from right to left, we accrue 1 (−1). The signs reverses if we pass
from left to right. In the event that (µk+1, νk+1) lies on the vertical line, we instead
consider the directed line segment from (µk, νk) to (µk+2, νk+2) (or an even larger
index if the second point is also on the vertical line) for the calculation. Under the
assumption that regions are either disjoint or nested, which is an assumption we make,
this calculation returns 0 if and only if the polygon defined by (µˆk, νˆk) is within the
polygon defined by (µk, νk).
Tissue information is captured with a tga image that is generated for each patient
image by flooding each tissue with a unique color. For example, the three segments
in Figure 10 would be linearly interpolated and the pixels within the outer polygon
but outside the inner polygons would be flooded with a color unique to kidney tissue.
This is possible with a PHP class that generates tga images, which are not stored
but rather generated as needed from the list of points in the database (this saves
storage requirements). Representative tga images for each tissue are displayed via a
web interface that additionally asks the user for the prescription information for each
tissue. Each dose point is associated with the closest pixel on a patient image, where
ties are decided with a least index rule. Thus, the tga images are the link between
the user defined prescription and the associated bounds of the optimization problem.
Another concern about tissue identification is that regions representing different
tissues may intersect. Our simple solution follows that of several commercial systems,
and we ask the user to rank tissues. In the case of an intersection, the dose points
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Figure 9: An enlarged view of a kid-
ney. The white areas are not kidney
and were delineated on the patient im-
ages.
Figure 10: The kidney was defined
for this patient image by three seg-
ments: an outer segment delineating
the larger volume and two inner seg-
ments that contain non-kidney tissue.
The points listed in the RTOG file are
indicated by small circles.
within the intersection are labeled as the tissue with the highest priority.
We have already defined the information available for the prescription in Table 1.
The Settings information details the dose point grid, the location of the possible
angles, and the type & sub-division of the beam. Whereas the information that
comprises a Problem details what is needed to design a treatment, a Solution ad-
ditionally includes the type of optimization model and the technique used to solve
it -i.e. it includes how we are defining and finding optimality. Hence, a Solution is
everything needed to define the anatomical dose of an optimal treatment, and with
this information it is possible to render a treatment to be evaluated.
8 Conclusion
Orchestrating the creation of a radiotherapy design system is a significant task that
lives at the application edge of operations research and computer science. This paper
has discussed many of the fundamental concerns and has introduced several new tac-
tics that allow the underlying optimization problem to be approached with standard
software, even in the case of numerous possible angles. It additionally introduces a
new method to draw isocontours. The system is based on an efficient and well studied
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radiation transport model.
Many researchers have faced the challenge of designing their own design software,
which is why there are several in-house, research systems. Our goal was to detail the
algorithmic and software perspectives of RAD so that others can incorporate our
experience as they either begin or continue their research. In the future, the authors
will initiate the process of a rigorous, detailed and wide-spread investigation into
which model and solution method consistently produces quality treatments. More-
over, RAD will allow others to compare their (new) techniques to ours with the same
dose model and patient information. Lastly, RAD is designed to accommodate the
amalgamation of beam selection and fluence optimization, a topic that is currently
receiving interest.
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